Movement Alert｜Smoore International Falls 3.01% in Regular Trading, Profit-Taking Persists After FDA-Driven Rally of Over 20%

Market Focus05-26

On May 26, Smoore International fell 3.01% in regular trading, trading at HK$9.76 per share, with trading volume of HK$16.20 million.

On the news front, the U.S. FDA previously approved for the first time a non-tobacco flavored e-cigarette product through its PMTA review process, which had propelled Smoore International shares up over 20% within the month. Since May 14, the stock has entered a sustained pullback phase. After a brief stabilization and rebound on May 22, the stock weakened again, with current price action continuing to reflect profit-taking pressure. Trading volume has contracted significantly, indicating pronounced wait-and-see sentiment among market participants.

Institutions remain constructive on the medium-to-long term thesis for Smoore International, noting that its underage-user identification technology was a key consideration in the FDA approval process. Core client products and the company's proprietary brands are expected to accelerate through the regulatory pipeline, positioning Smoore as a direct beneficiary of the compliant market recovery.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1127452312?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-26 10:13","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1127452312","market":"us","top_or_hot":-1,"title":"Movement Alert｜Smoore International Falls 3.01% in Regular Trading, Profit-Taking Persists After FDA-Driven Rally of Over 20%","media":"Market Focus","content":"<p><p>On May 26, Smoore International fell 3.01% in regular trading, trading at HK$9.76 per share, with trading volume of HK$16.20 million.</p><p>On the news front, the U.S. FDA previously approved for the first time a non-tobacco flavored e-cigarette product through its PMTA review process, which had propelled Smoore International shares up over 20% within the month. Since May 14, the stock has entered a sustained pullback phase. After a brief stabilization and rebound on May 22, the stock weakened again, with current price action continuing to reflect profit-taking pressure. Trading volume has contracted significantly, indicating pronounced wait-and-see sentiment among market participants.</p><p>Institutions remain constructive on the medium-to-long term thesis for Smoore International, noting that its underage-user identification technology was a key consideration in the FDA approval process. Core client products and the company's proprietary brands are expected to accelerate through the regulatory pipeline, positioning Smoore as a direct beneficiary of the compliant market recovery.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Smoore International Falls 3.01% in Regular Trading, Profit-Taking Persists After FDA-Driven Rally of Over 20%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Smoore International Falls 3.01% in Regular Trading, Profit-Taking Persists After FDA-Driven Rally of Over 20%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-05-26 10:13</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On May 26, Smoore International fell 3.01% in regular trading, trading at HK$9.76 per share, with trading volume of HK$16.20 million.</p><p>On the news front, the U.S. FDA previously approved for the first time a non-tobacco flavored e-cigarette product through its PMTA review process, which had propelled Smoore International shares up over 20% within the month. Since May 14, the stock has entered a sustained pullback phase. After a brief stabilization and rebound on May 22, the stock weakened again, with current price action continuing to reflect profit-taking pressure. Trading volume has contracted significantly, indicating pronounced wait-and-see sentiment among market participants.</p><p>Institutions remain constructive on the medium-to-long term thesis for Smoore International, noting that its underage-user identification technology was a key consideration in the FDA approval process. Core client products and the company's proprietary brands are expected to accelerate through the regulatory pipeline, positioning Smoore as a direct beneficiary of the compliant market recovery.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06969","symbol_name":"思摩尔国际","start_time":0,"source_url":"","article_id":"1127452312","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1127452312","pubTimestamp":1779761612,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On May 26, Smoore International fell 3.01% in regular trading, trading at HK$9.76 per share, with trading volume of HK$16.20 million.On the news front, the U.S. FDA previously approved for the first...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06969":"思摩尔国际"},"translate_title":"动向提示|思摩尔国际常规交易跌3.01%FDA带动反弹超20%后获利了结持续","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06969":1},"content_text":"On May 26, Smoore International fell 3.01% in regular trading, trading at HK$9.76 per share, with trading volume of HK$16.20 million.On the news front, the U.S. FDA previously approved for the first time a non-tobacco flavored e-cigarette product through its PMTA review process, which had propelled Smoore International shares up over 20% within the month. Since May 14, the stock has entered a sustained pullback phase. After a brief stabilization and rebound on May 22, the stock weakened again, with current price action continuing to reflect profit-taking pressure. Trading volume has contracted significantly, indicating pronounced wait-and-see sentiment among market participants.Institutions remain constructive on the medium-to-long term thesis for Smoore International, noting that its underage-user identification technology was a key consideration in the FDA approval process. Core client products and the company's proprietary brands are expected to accelerate through the regulatory pipeline, positioning Smoore as a direct beneficiary of the compliant market recovery.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1127452312","isCrawlerRequest":true}